Research: By Our Experts

Liang BA*, Mackey TK. Vaccine shortages and suspect online pharmacy sellers. Vaccine (2011), doi:10.1016/j.vaccine.2011.11.016  (November 15, 2011)

Liang BA.*, Mackey TK. Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising. J Med Internet Res 2011;13(3):e64 (August 31, 2011)

Liang BA.*, Mackey TK. Promoting online drug safety: Using Public–Private Partnerships to Deter Illicit Online Drug Sales. J Commer Biotechnol. (2011) 17, 266–271 (July 12, 2011)

Shcherbakova N, Shepherd M*, Lawson K, and Richards K. The role of authorized generics in the prescription drug marketplace. Journal of Generic Medicines. 2011; 8(1):28-40. (April 19, 2011)

Liang B A*, Mackey T. Direct-to-Consumer Advertising With Interactive Internet Media. JAMA. 2011 2 23; 305 (8): 824-825. (February 23, 2011)

Liang BA.*, Mackey T. Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales. Am J Law Med. 2009;35:125-184.  (December 10, 2010)

Gavaza P, Shepherd MD*, Shcherbakova N, Khoza S. The state of health economics and pharmacoeconomics research in Russia: a systematic review. Journal of Pharmaceutical Health Services Research. 2010 Sept; 1(3):113-21. (September 01, 2010)

Shepherd MD.* The effect of US pharmaceutical drug importation on the Canadian pharmaceutical supply. Can Pharm J. 2010 Sept/Oct; 143(5):226-33. (September 01, 2010)

Shepherd MD*, The effect of US pharmaceutical importation on the Canadian drug supply. CPJ. 2010 Sept/Oct; 143(5):226-33. (September 01, 2010)

Shepherd, MD*. Black medicine. AQ. 2010 Summer; 4(3):82-5. (July 29, 2010)

Shepherd M.* Beef up international cooperation on counterfeits. Nat Med. 2010;16(4):366. (April 16, 2010)

Dai XM, An N Wu JM, Li HY, Zhang QM. Development and Validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products. Yao Xue Xue Bao. 2010 Mar; 45(3):347-52. (March 01, 2010)

Kubic TT.* Law Enforcement and Industry: Key Partners for Safe Medicines. J Biolaw Bus. 2010;13(1&2):38-41. (January 01, 2010)

Liang BA.* International Drug Production and Supply: Challenges for Biopreparedness. J Biolaw Bus. 2010;12(3): 31- 34. (January 01, 2010)

Liang BA.* Supporting Pharmaceutical Diversion and Counterfeiting Prosecutions: A Role for Medical Professionals. J Biolaw Bus. 2010;13(1&2): 55-57. (January 01, 2010)

Winegar A, Shepherd MD*, Lawson KA, Richards K. Comparison of claim percent gross margin earned by Texas community independent pharmacies for dual-eligible beneficiaries claims before and after Medicare Part D. J Am Pharm Assoc. 2009 Sept/Oct; 49(5):617-2 (September 01, 2009)

Liang BA.* Pigs, Drugs, and Terrorists. Patient Safe Qual Healthcare. 2008 Nov 1:10-12 (November 01, 2008)

Panjabi SS, Panjabi RS, Shepherd MD*, Lawson KA, Johnsrud M, Barner J. Extended-release, once-daily morphine (Avinza) for the treatment of chronic nonmalignant pain: effect on pain, depressive symptoms, and cognition. Pain Medicine. 2008 Aug; 9(8):985-93. (August 07, 2008)

Liang BA.* Safety Issues in Regulating Follow-On Biologic Drugs. J BIolaw Bus. 2007;10(4):44-49. (December 07, 2007)

Kubic TT.* Beer Cooler Biologics! J Biolaw Bus. 2007;10(4):28-32. (December 07, 2007)

Class JN.* Behind the Curve: A Critique of NGO Activity with regards to the Safety Concerns of Biologics. J Biolaw Bus. 2007;10(4):33-36. (December 07, 2007)

Liang BA.* A Dose of Reality: Promoting Access to Pharmaceuticals. Wake Forest Intell Prop LJ. 2007 Dec 1;8:301-386 (December 01, 2007)

Shepherd MD*, Richards KM, Winegar AL. Prescription drug payment times by Medicare Part D plans: results of a national study. J Am Pharm Assoc. 2007 Nov/Dec; 47(6):695-701. (November 01, 2007)

Shepherd, M.* Drug Importation and Safety of Drugs Obtained from Canada. Ann Pharmacother. 2007;41:1288-1291. (June 19, 2007)

Shepherd, M.* Impact of drug importation on community pharmacy and patient care. J Am Pharm Assn. 2007; 47(3):319-327 (May 27, 2007)

Shepherd MD.* Impact of Drug Importation on Community Pharmacy and Patient Care. J Am Pharm Assoc. 2007 May-Jun ;47:319-20, 323-4, 327 (May 01, 2007)

Kubic TT,* Mollo SJ. Pharmaceutical Counterfeiting Trends: Understanding The Extent of Criminal Activity. J Biolaw Bus. 2006;9(4):51-56. (December 07, 2006)

Liang BA.* Crime, Terrorism, and Counterfeit Drugs: Addressing the International Regime. J Biolaw Bus. 2006;9(4): 36-40. (December 07, 2006)

Liang BA.* Structurally Sophisticated or Lamentably Limited? Mechanisms to Ensure Safety of the Medicine Supply. Albany Law J Sci Technol. 2006;16(3):483-524 (June 01, 2006)

Liang BA.* Parallel Trade in Pharmaceuticals: Injecting the Counterfeit Element into the Public Health. NC J Int Law Com Reg. 2006;31(4):847-900 (June 01, 2006)

Liang BA.* The Scourge of Counterfeit Drugs: No Easy Answers. J Biolaw Bus. 2006;9(2):3-7. (April 07, 2006)

Liang BA.* Fade to Black: Importation and Counterfeit Drugs. Am J Law Med. 2006 Feb 1;32(2-3):279-323 (February 01, 2006)

Liang BA.* Measuring the Impact of Counterfeit Drugs: Applying the Patient Safety Reporting System Approach. Proceedings of the OECD/WIPO meeting on measurement of counterfeiting and piracy, 17-18 October 2005. (October 17, 2005)

Liang BA.* Over The Virtual and Geographic Borders: Understanding Importation and Counterfeit Drugs. Cal W Int Law J. 2005 Jun 3;36(1):7-18 (June 03, 2005)

Liang BA.* International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health. Cal W Int Law J. 2005 Jun 3;36(1):1-6 (June 03, 2005)

EVENTS

Miss the conference? Read our liveblog

Get Breaking News

Get weekly counterfeit news and immediate safety alerts by email

       

Drug Safety Alert

Counterfeit Drug Incident Encyclopedia

Our counterfeit drug incident encyclopedia documents key incidents worldwide of counterfeit drugs in the legitimate drug supply.